CB 30865
CB 30865 Basic information
- Product Name:
- CB 30865
- Synonyms:
-
- CB 30865
- ZM 242421
- ZM242421
- ZM-242421
- 4-[[(7-Bromo-1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-N-(3-pyridinylmethyl)benzamide
- Benzamide, 4-[[(7-bromo-3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]-2-propyn-1-ylamino]-N-(3-pyridinylmethyl)-
- 4-(((7-bromo-2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)(prop-2-yn-1-yl)amino)-n-(pyridin-3-ylmethyl)benzamide
- CAS:
- 206275-15-2
- MF:
- C26H22BrN5O2
- MW:
- 516.38918
- Mol File:
- 206275-15-2.mol
CB 30865 Chemical Properties
- Density
- 1.38±0.1 g/cm3(Predicted)
- storage temp.
- Store at 0-8 °C
- solubility
- DMSO : 33.33 mg/mL (64.54 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
- form
- Powder
- pka
- 14.31±0.46(Predicted)
- color
- White to off-white
CB 30865 Usage And Synthesis
Uses
CB30865 (ZM 242421) is a nicotinamide phosphoribosyltransferase (Nampt) inhibitor, with potent cytotoxicity. CB30865 is highly potent against a variety of human tumour cell lines (IC50 values in the 1-10 nM range)[1][2]. CB30865 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
References
[1] Fleischer TC, et al. Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. Chem Biol. 2010 Jun 25;17(6):659-664. DOI:10.1016/j.chembiol.2010.05.008
[2] Skelton LA, et al. Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action. Cytometry. 1998 Sep 1;33(1):56-66. DOI:10.1002/(sici)1097-0320(19980901)33:13.0.co;2-9
CB 30865Supplier
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- eric_feng1954@126.com
- Tel
- 18620099427
- amy@howeipharm.com